| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |